These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15306945)

  • 21. GATA3 immunohistochemical expression in invasive urothelial carcinoma.
    Mohammed KH; Siddiqui MT; Cohen C
    Urol Oncol; 2016 Oct; 34(10):432.e9-432.e13. PubMed ID: 27241168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prostatic adenocarcinoma showing features of endometrioid and mucinous carcinomas: a case report].
    Nishimura K; Higashino M; Hara T; Oka T
    Hinyokika Kiyo; 1995 Oct; 41(10):805-7. PubMed ID: 8533679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study.
    Oxley JD; Abbott CD; Gillatt DA; MacIver AG
    Br J Urol; 1998 Jan; 81(1):109-15. PubMed ID: 9467486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare histological patterns of prostatic ductal adenocarcinoma.
    Lee TK; Miller JS; Epstein JI
    Pathology; 2010 Jun; 42(4):319-24. PubMed ID: 20438402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostatic Ductal Adenocarcinoma with Papillary Features in a Bladder Washing: A Possible Pitfall in Urinary Cytology - Report of One Case.
    Barizzi J; Freguia S; Sarro R; Venzi G; Fulciniti F
    Acta Cytol; 2020; 64(6):607-611. PubMed ID: 32498072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenocarcinomas of the prostatic duct in necropsy material.
    Stamatiou K; Alevizos A; Mariolis A; Fanou D; Alevizou A; Michalodimitrakis E; Sofras F
    Can J Urol; 2007 Apr; 14(2):3502-6. PubMed ID: 17466156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.
    Rioux-Leclercq N; Leray E; Patard JJ; Lobel B; Guillé F; Jouan F; Bellaud P; Epstein JI
    Hum Pathol; 2005 May; 36(5):531-5. PubMed ID: 15948120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
    Ormsby AH; Haskell R; Jones D; Goldblum JR
    Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
    Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
    J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The androgen receptor revisited in urothelial carcinoma.
    Birtle AJ; Freeman A; Munson P
    Histopathology; 2004 Jul; 45(1):98-9. PubMed ID: 15228457
    [No Abstract]   [Full Text] [Related]  

  • 32. Endometrioid adenocarcinoma of prostatic urethra presenting with anterior urethral implantation.
    Aydin F
    Urology; 1993 Jan; 41(1):91-5. PubMed ID: 8420091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-grade Adenocarcinoma of the Prostate Mimicking Urothelial Carcinoma is Negative for TERT Mutations.
    Alaghehbandan R; Vanecek T; Trpkov K; Comperat E; Kristiansen G; Svajdler M; Cempirkova D; Pavlovsky M; Pivovarcikova K; Stehlikova A; Hora M; Michal M; Hes O
    Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):523-528. PubMed ID: 31393284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
    Huguet J
    Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of ductal adenocarcinoma of the prostate treated with endocrine therapy and radiation therapy].
    Suzuki T; Shinbo H; Kurita Y; Furuse H; Mugiya S; Ozono S
    Hinyokika Kiyo; 2011 May; 57(5):261-4. PubMed ID: 21743285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Papillary adenocarcinoma of the prostate: report of 4 cases].
    Miki J; Ikemoto I; Shimomura T; Kiyota H; Oisi Y; Kondo I; Madarame J; Endo K; Takahashi H
    Hinyokika Kiyo; 2003 Jan; 49(1):21-4. PubMed ID: 12629776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
    Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
    Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostatic duct adenocarcinoma with endometrioid features: immunohistochemical and electron microscopic study.
    Ro JY; Ayala AG; Wishnow KI; Ordóñez NG
    Semin Diagn Pathol; 1988 Aug; 5(3):301-11. PubMed ID: 2845546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.
    Hong H; Kao C; Jeng MH; Eble JN; Koch MO; Gardner TA; Zhang S; Li L; Pan CX; Hu Z; MacLennan GT; Cheng L
    Cancer; 2004 Jul; 101(1):83-9. PubMed ID: 15221992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.